- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 699-713 of
1,371 results
2110 Exhibit: JSN 2110 JJ January 22, 2013 Press Release Johnson Johnson Rep...
Document
IPR2016-01582, No. 2110-187 Exhibit - JSN 2110 JJ January 22, 2013 Press Release Johnson Johnson Reports 2012 Fourth Quarter and Full Year Results (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2090 Exhibit: JSN 2090 Tucker et al, Reversible Adrenal Insufficiency Induced by K...
Document
IPR2016-01582, No. 2090-169 Exhibit - JSN 2090 Tucker et al, Reversible Adrenal Insufficiency Induced by Ketoconazole, JAMA, 253162413 2414 1985 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2131 Exhibit: JSN 2131 Van den Akker et al, Differential Inhibition of 17a Hydroxyla...
Document
IPR2016-01582, No. 2131-201 Exhibit - JSN 2131 Van den Akker et al, Differential Inhibition of 17a Hydroxylase and 17,20 Lyase Activities by Three Novel Missense CYP17Mutations Identified i...
|
|
Cite Document
2132 Exhibit: JSN 2132 Order Granting Janssens Motion to Set a Hearing and Corr...
Document
IPR2016-01582, No. 2132-202 Exhibit - JSN 2132 Order Granting Janssens Motion to Set a Hearing and Correct Inventorship of the 438 Patent (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2080 Exhibit: JSN 2080 Antonarakis and Eisenberger, Phase III Trials With Docetax...
Document
IPR2016-01582, No. 2080-159 Exhibit - JSN 2080 Antonarakis and Eisenberger, Phase III Trials With Docetaxel Based Combinations for Metastatic Castration Resistant Prostate Cancer Time to...
|
|
Cite Document
2056 Exhibit: JSN 2056 Sternberg, Hormone refractory metastatic prostate cancer...
Document
IPR2016-01582, No. 2056-135 Exhibit - JSN 2056 Sternberg, Hormone refractory metastatic prostate cancer, Annals of Oncology, 3331 335 1992 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2043 Exhibit: JSN 2043 Armstrong and Carducci, New drugs in prostate cancer, Cu...
Document
IPR2016-01582, No. 2043-122 Exhibit - JSN 2043 Armstrong and Carducci, New drugs in prostate cancer, Current Opinions Urology, 16138 145 2006 (P.T.A.B. Mar. 17, 2017)
|
|
Cite Document
2157 Exhibit: JSN 2157 Sweeney, ECOG 3805 CHAARTED ChemoHormonal Thera...
Document
IPR2016-01582, No. 2157-226 Exhibit - JSN 2157 Sweeney, ECOG 3805 CHAARTED ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate C...
|
|
Cite Document
1029 Exhibit: CORRECTED Ex 1029 US Patent 5,688,977
Document
IPR2017-00853, No. 1029-79 Exhibit - CORRECTED Ex 1029 US Patent 5,688,977 (P.T.A.B. Mar. 9, 2017)
|
|
Cite Document
1075 Exhibit: Ex 1075 May 9, 2014 IDS 438 patent
Document
IPR2017-00853, No. 1075-60 Exhibit - Ex 1075 May 9, 2014 IDS 438 patent (P.T.A.B. Feb. 8, 2017)
|
|
Cite Document
1013 Exhibit: Ex 1013 Jul, 3 2013 NOA 438 patent
Document
IPR2017-00853, No. 1013-13 Exhibit - Ex 1013 Jul, 3 2013 NOA 438 patent (P.T.A.B. Feb. 8, 2017)
|
|
Cite Document
1006 Exhibit: Ex 1006 Tannock 1996
Document
IPR2017-00853, No. 1006-6 Exhibit - Ex 1006 Tannock 1996 (P.T.A.B. Feb. 8, 2017)
|
|
Cite Document
1015 Exhibit: Ex 1015 Feb 11,2014 NOA 438 patent
Document
IPR2017-00853, No. 1015-15 Exhibit - Ex 1015 Feb 11,2014 NOA 438 patent (P.T.A.B. Feb. 8, 2017)
|
|
Cite Document
1017 Exhibit: Ex 1017 Declaration of Ivan T Hofmann
Document
IPR2017-00853, No. 1017-17 Exhibit - Ex 1017 Declaration of Ivan T Hofmann (P.T.A.B. Feb. 8, 2017)
|
|
Cite Document
2009 Exhibit: JSN 2009 2015 09 01 DI 35 Sun Pharmaceuticals Industries, Inc Waiv...
Document
IPR2017-00853, No. 2009-75 Exhibit - JSN 2009 2015 09 01 DI 35 Sun Pharmaceuticals Industries, Inc Waiver of Service (P.T.A.B. Mar. 8, 2017)
|
|
Cite Document
